1833PDLack of efficiency of precision oncology with target-based investigational treatments for patients in early phase clinical trials based on pre-screened molecular alterations. (23rd October 2018) - Doger de Spéville, B; Moreno, V; Hernandez, T; Boni, V; de Miguel, M J; Rojo, F; Lopez-Rios, F; Calvo, E